CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851623397
- Phone
- 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-26 | FMR LLC See Remark 1 | Conversion | +789,473 | 815,788 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion | +686,499 | 1,502,287 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion | +28,703 | 1,530,990 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion | +372,215 | 372,215 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion | +4,465 | 4,465 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion · Series A Preferred Stock | −7,500,000 | 0 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion · Series A-1 Preferred Stock | −6,521,739 | 0 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion · Series B Preferred Stock | −272,687 | 0 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion · Series B Preferred Stock | −3,536,046 | 0 | ||
| 2021-10-26 | FMR LLC See Remark 1 | Conversion · Series B Preferred Stock | −42,421 | 0 | ||
| 2021-10-26 | Alexandria Venture Investments, LLC 10% owner | Conversion | +166,423 | 166,423 | ||
| 2021-10-26 | Alexandria Venture Investments, LLC 10% owner | Conversion · Series B convertible preferred stock | −1,581,026 | 0 | ||
| 2021-10-26 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion | +1,475,121 | 1,475,121 | ||
| 2021-10-26 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion · Series B Preferred Stock | −1,248,180 | 0 | ||
| 2021-10-26 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion · Series C Preferred Stock | −226,941 | 0 | ||
| 2021-10-26 | Rock Springs Capital Management LP 10% owner | Conversion | +756,472 | 756,472 | ||
| 2021-10-26 | Rock Springs Capital Management LP 10% owner | Conversion | +151,294 | 151,294 | ||
| 2021-10-26 | Rock Springs Capital Management LP 10% owner | Purchase | +500,000 | $16.00 | $8.0M | 1,256,472 |
| 2021-10-26 | Rock Springs Capital Management LP 10% owner | Conversion · Series C Preferred Stock | −7,186,490 | 0 | ||
| 2021-10-26 | Rock Springs Capital Management LP 10% owner | Conversion · Series C Preferred Stock | −1,437,297 | 0 |
Page 11 of 12 · 224 trades